Metabolic Inflexibility is Related to Elevated Muscle Anaerobic Glycolysis
1 other identifier
observational
100
1 country
1
Brief Summary
The focus of this proposal is on overweight (25\>BMI\<30 kg/m2) subjects, as these individuals exhibit a high risk of becoming obese and/or developing metabolic diseases. We hypothesize that in some overweight individuals there is a "metabolic program" in skeletal muscle which predisposes them to the development of obesity. Findings may lead to clinical screening tools for determining risk for obesity in non-obese individuals and targeting this group for prevention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 3, 2019
CompletedStudy Start
First participant enrolled
March 3, 2020
CompletedFirst Posted
Study publicly available on registry
March 24, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedAugust 7, 2025
August 1, 2025
5.8 years
September 3, 2019
August 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Carbohydrate/fat oxidation (RER) in the fasting condition.
RER will be measured from indirect calorimetry
Years 1-5
Muscle oxygen consumption (substrate oxidation) in the fasting condition.
Muscle oxygen consumption will be measured by near-infrared spectroscopy (NIRS)
Years 1-5
Muscle lactate release in the fasting condition.
Muscle lactate release will be measured by microdialysis
Years 1-5
Change in Carbohydrate/fat oxidation (RER) in response to glucose + insulin (metabolic flexibility)
Indirect calorimetry during glucose clamp
Years 1-5
Change in muscle fat oxidation in response to high fat feeding (metabolic flexibility).
Oxidation of fatty acid in muscle homogenate.
Years 1-5
Change in muscle oxygen consumption (substrate oxidation) in response to high fat feeding (metabolic flexibility).
Oxygen consumption measured by near-infrared spectroscopy (NIRS)
Years 1-5
Secondary Outcomes (2)
Insulin sensitivity (clamp M value).
Years 1-5
Endogenous glucose production in the fasting condition.
Years 1-5
Study Arms (3)
Low oxidizers/high lactate
Individuals with low aerobic oxidation
High oxidizers/low lactate
Individuals with high aerobic oxidation
Obese
Severely obese scheduled for surgery
Interventions
Eligibility Criteria
High oxidizers Low oxidizers Obese
You may qualify if:
- years old
- BMI of 25 - 30 kg/m2
- BMI \> 40kg/m2
- Lactate levels in top and lower 25%
You may not qualify if:
- Pregnant women
- Mentally disabled
- Prisoners
- Smokers
- Subjects with heart disease
- Type 1 and 2 diabetes
- Endocrine disease
- Hypertension
- Musculoskeletal disease
- Peripheral occlusion
- Hepatic disease
- Have had weight fluctuations exceeding + 3% in the previous 12 months
- On medications which alter carbohydrate metabolism will not be studied
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- East Carolina Universitylead
- Duke Universitycollaborator
- University of Arkansascollaborator
Study Sites (1)
East Carolina University
Greenville, North Carolina, 27834, United States
Related Publications (5)
Ryan TE, Brophy P, Lin CT, Hickner RC, Neufer PD. Assessment of in vivo skeletal muscle mitochondrial respiratory capacity in humans by near-infrared spectroscopy: a comparison with in situ measurements. J Physiol. 2014 Aug 1;592(15):3231-41. doi: 10.1113/jphysiol.2014.274456. Epub 2014 Jun 20.
PMID: 24951618BACKGROUNDCamisa C, Rossana C. Variant of keratoderma hereditaria mutilans (Vohwinkel's syndrome). Treatment with orally administered isotretinoin. Arch Dermatol. 1984 Oct;120(10):1323-8.
PMID: 6237617BACKGROUNDCraglietto T, Giarelli L, Paolini A. [Comparative study of the DNA content of human female breast adenocarcinomas and of their recurrences. (Histo-spectrophotometric findings)]. Riv Anat Patol Oncol. 1964 Nov-Dec;26(5):694-706. No abstract available. Italian.
PMID: 5866193BACKGROUNDCiresa M, Gabl F, Knapp E. [Acid-base equilibrium]. Wien Klin Wochenschr. 1970 Jan 2;82(1):11-2. No abstract available. German.
PMID: 5513193BACKGROUNDIwamasa J, Tajima C, Matsuura K, Okamura H. [Role of progesterone in the ovulatory process of PMSG/hCG treated immature female rats]. Nihon Sanka Fujinka Gakkai Zasshi. 1989 Oct;41(10):1551-6. Japanese.
PMID: 2584808BACKGROUND
Biospecimen
Blood and tissue samples without analysis of DNA
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joseph Houmard, PhD
East Carolina University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2019
First Posted
March 24, 2020
Study Start
March 3, 2020
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
August 7, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share